Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   RAC December 4, 2003 - Presentation Materials 94th Meeting Day 2 Bethesda, Maryland Discussion of Human Gene Transfer Protocol #0307-589     A Phase 1 Study in Glaucoma Subjects Receiving SCH 412499 (rAd-p21) Administered as a Single Injection into the Subconjunctival Space Prior to Primary Trabeculectomy     Paul L. Kaufman, M.D., University of Wisconsin Medical School, Madison Robert N. Weinreb, M.D., University of California, San Diego     Slides     NIH Guidance on Informed Consent for Gene Transfer Research     Nancy M.P. King, J.D., University of North Carolina, Chapel Hill Sue L. Levi-Pearl, Tourette's Syndrome Association, Inc., Bayside, NY     Slides     Discussion of Human Gene Transfer Protocol #0307-592     A Phase 1 Study to Determine the Safety and Immunogenicity of Vaccination With Listeria Monocytogenes Expressing Human Papillomavirus Type 16 E7 for the Treatment of Progressive, Recurrent, and Advanced Squamous Cell Cancer of the Cervix     John Marshall, M.D., Georgetown University Medical Center, Washington, DC     Slides     ADJOURN     Top of Page

6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov

RDNA316